+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Marijuana - Global Market Trajectory & Analytics

  • ID: 5309784
  • Report
  • April 2021
  • Region: Global
  • 114 pages
  • Global Industry Analysts, Inc
Global Medical Marijuana Market to Reach $37.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Medical Marijuana estimated at US$13.8 Billion in the year 2020, is projected to reach a revised size of US$37.9 Billion by 2027, growing at a CAGR of 15.5% over the analysis period 2020-2027. Pain Management, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$29.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Muscle Spasms segment is readjusted to a revised 14.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $4.1 Billion, While China is Forecast to Grow at 14.8% CAGR

The Medical Marijuana market in the U.S. is estimated at US$4.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.6 Billion by the year 2027 trailing a CAGR of 14.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.8% and 13.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Nausea Segment to Record 10.3% CAGR

In the global Nausea segment, USA, Canada, Japan, China and Europe will drive the 10.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$508.7 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.5 Billion by the year 2027.

Select Competitors (Total 44 Featured):
  • ABcann Medicinals, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corporation
  • Emerald Health Therapeutics Inc.
  • Green Relief Inc.
  • GW Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Maricann Group, Inc.
  • mCig, Inc.
  • Medical Marijuana, Inc.
  • The Cronos Group Inc.
  • The Supreme Cannabis Company
  • Tilray
  • United Cannabis
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Muscle Spasms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Muscle Spasms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Nausea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Nausea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 11: USA Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 12: USA 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • CANADA
  • Table 13: Canada Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 14: Canada 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • JAPAN
  • Table 15: Japan Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 16: Japan 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • CHINA
  • Table 17: China Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 18: China 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • EUROPE
  • Table 19: Europe Current & Future Analysis for Medical Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: Europe 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 21: Europe Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 22: Europe 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • FRANCE
  • Table 23: France Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 24: France 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • GERMANY
  • Table 25: Germany Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 26: Germany 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • ITALY
  • Table 27: Italy Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: Italy 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 29: UK Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: UK 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 31: Rest of Europe Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: Rest of Europe 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 33: Asia-Pacific Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: Asia-Pacific 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
  • REST OF WORLD
  • Table 35: Rest of World Current & Future Analysis for Medical Marijuana by End-Use - Pain Management, Muscle Spasms, Nausea and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Rest of World 7-Year Perspective for Medical Marijuana by End-Use - Percentage Breakdown of Value Sales for Pain Management, Muscle Spasms, Nausea and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll